• PureTech lifted by news of Roche deal pharmatimes
    July 23, 2018
    Shares in UK-based clinical-stage biopharm PureTech Health have been given a boost by news that Roche has signed up to advance its exosome platform technology in a deal potentially worth more than $1 billion.
PharmaSources Customer Service